Extranet Access  |  Contact Info  |  866.222.0112
When you're serious about intellectual property... UseBrinks

Meredith Martin Addy

Chicago
312.321.4280
312.321.4299 (fax)
Washington, DC
202.296.6916
202.296.8701 (fax)
maddy@usebrinks.com

View Expanded Bio
Download VCARD

Practice Summary

Ms. Addy is chair of the firm's Appellate Group and focuses on appeals before the U.S. Court of Appeals for the Federal Circuit and intellectual property cases in the federal courts. She is a member of the Federal Circuit's Advisory Council and has testified on the State of the Federal Circuit and Patent Appeals before a Subcommittee of Congress.

As lead counsel, Ms. Addy has successfully prepared cases on appeal from U.S. district courts as well as the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences. She is able to present difficult legal issues intertwined with complex technology clearly to the Court both in briefs and at oral argument. Clients appreciate her "significant business knowledge," and peers commend her "direct and forthright approach." Chambers U.S.A. She is admired as a "litigator and appellate lawyer, spreading her talents across the biotech, pharmaceutical, chemical and electronics arenas." Legal 500.

"She stands out because she's so well prepared," remarked Chief Judge Michel when interviewed for the article, "The Quick Rise of Meredith Addy," William Wagner, Superlawyers.com (2009). "[W]hen you ask her a difficult question, as we often do in oral arguments, she fires right back with a very crisp, clear answer that is totally responsive to the question. And, it's factual and accurate and fair. The contrast with other attorneys is stark. Most of the other attorneys duck the questions. She answers them head-on."

Ms. Addy is the immediate past President of the IP-focused Richard Linn American Inn of Court. She serves as an editor of Claim Construction in the Federal Circuit, published by West LegalWorks. Ms. Addy is a former chair of the Amicus Committee for the American Intellectual Property Law Association, and a former member of the firm's Executive Committee and Board of Directors. She is active with veterans' organizations preparing cases at the Federal Circuit and at the Supreme Court of the United States.

Honors/Distinctions
View All
  • Named as one of the top 10 “Super Lawyers” in Illinois for 2008 by Law & Politics magazine
  • Named a Leading Illinois Intellectual Property Lawyer by Chambers USA: America’s Leading Lawyers for Business for 2006-2008, and 2009
  • Named to the Legal 500 for 2007 and 2008
  • Represented Clients From Three of the “Top 13 Patent Cases of 2007,” as reported by the IPO Daily NewsTM
  • Named in The Best Lawyers of America for 2007-09, and 2010
  • Named as one of the top 50 female "Super Lawyers" in Illinois for 2005 through 2010 by Law & Politics magazine
  • Named among the Top 10 Leading Women Business Lawyers in Illinois for 2005 and 2009 by Leading Lawyers Network magazine
  • Named as one of the top 100 "Super Lawyers" in Illinois for 2005 through 2010 by Law & Politics magazine
  • Named to Law Bulletin's “40 Illinois Attorneys Under Forty to Watch” for 2004
  • Notes Editor, University of Georgia Journal of Intellectual Property Law, 1993
Representative Matters
Appeals
View All
  • Abraxis Bioscience v. Navinta LLC , 2009-1539 (Fed. Cir. 2009).  Lead counsel for Appellant Navinta accused of infringing Abraxis patents relating to Naropin® and generic Ropivaccine Hydrochloride.
  • Lexion Med. Inc. v. Northgate Techs., Inc., 2009-1494 (Fed. Cir. 2009).  Lead counsel for Appellant Northgate in appeal of summary judgment decision on patent concerning medical device relating to laparoscopic surgery.
  • Abbott Labs. v. Sandoz Inc., 566 F.3d 1282 (Fed. Cir. 2009) (partially en banc), cert. denied, 09-335 (2010). Lead counsel for Appellant Sandoz over patents relating to the antibiotic Omnicef® and generic Cefdinir.
  • Bilski v. Doll, 561 U.S. ___ (2010).  Supporting reversal of the Federal Circuit’s holding that the machine or transformation test is the exclusive test for patent eligibility of method patents. Counsel of record for Accenture as amicus curiae.
  • Boss v. Cabilly, No. 2009-1264 (Fed. Cir. 2009). Lead counsel for Appellee Genentech on defense of an appeal from an interference.
  • In re Byerly, No. 2008-1408 (Fed. Cir. 2009). Lead counsel for Appellant Kimberly-Clark on appeal from the Patent and Trademark Board of Appeals and Interferences.
  • In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc). Counsel of record for the American Intellectual Property Law Association (AIPLA) as amicus curiae.
  • Nuijten v. Dudas, 129 S.Ct. 70 (2008). Represented the American Intellectual Property Law Association (AIPLA) as amicus curiae on petition for certiorari.
  • Aventis Pharma. S.A. v. Sandoz Inc., 2008-1560 (Fed. Cir. 2008). Represented Sandoz in defense of favorable summary judgment decision on collateral estoppel relating to Aventis's Lovenox® and Sandoz forms of Enoxaparin.
  • Lexion Med. Inc. v. Northgate Techs., Inc., 292 Fed. Appx. 42 (Fed. Cir. 2008). Lead counsel for Appellant Northgate in appeal of a district court decision on claim construction and alleged infringement of patent concerning medical device relating to laparoscopic surgery.
  • MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007). Counsel for Genentech. The Supreme Court held under Article III that a licensee was not required to terminate the license before seeking a declaratory judgment that the underlying patent was invalid, unenforceable, or not infringed.
  • KSR Int'l Co. v. Teleflex, Inc.,550 U.S. 398 1727 (2007). Represented Chemistry and Bioengineering Professors as amici curiae on 35 U.S.C. § 103 issue.
  • Brand & Capital Mach. Co. v. Miller, 487 F.3d 862 (Fed. Cir. 2007). Lead counsel for Appellant Capital Machine for reversal of an interference decision.
  • MedImmune, Inc. v. Genentech, Inc., 427 F.3d 958 (2005). Counsel for Appellee Genentech on appeal of dismissal of all declaratory judgment claims of patent invalidity, unenforceability, antitrust, and unfair competition for lack of a case or controversy.
  • Chiron Corp. v. Genentech, Inc., 363 F.3d 1247 (Fed. Cir. 2004). Represented Appellee Genentech in a successful defense that Chiron's asserted patent is invalid and Genentech's breast cancer drug Herceptin® does not infringe.
  • Knorr-Bremse Systeme Fuer Nutzfahrzeuge GmbH v. Dana Corp., 383 F.3d 1337 (Fed. Cir. 2004) (en banc). Represented City of Chicago as amicus curiae.
  • In re Omeprazole Patent Litigation, 84 Fed. Appx. 76 (Fed. Cir. 2003). Counsel for Appellant Andrx Pharmaceuticals, Inc. in a multiparty appeal concerning Prilosec® and the generic Omeprazole.
  • In re Doyle, 293 F.3d 1355 (Fed. Cir. 2002). Lead counsel for Patentee in successful reversal of chemical decision from the Board of Patent Appeals and Interferences denying a reissue patent.
  • In re Glaug, 283 F.3d 1335 (Fed. Cir. 2002). Lead counsel for Kimberly-Clark on successful reversal of decision of the Board of Patent Appeals and Interferences.
  • JBL, Inc. v. Bose Corp., No. 02-46 (U.S.S.Ct. 2002). Lead counsel for petitioner JBL, Inc.
  • Bose Corp. v. JBL, Inc., No. 02-1282 (Fed. Cir. 2002). Lead counsel for appellant JBL, Inc.
  • Bio-Technology Gen. Corp. v. Genentech, Inc., 267 F.3d 1325 (Fed. Cir. 2001). Counsel for Genentech on successful appeal reversing JMOL and reinstating jury verdict on a method of manufacturing human growth hormone.
Court Appointed Expert/Special Master Cases
View All
  • Nuance Commn’s, Inc. v. eCopy, Inc., 08-cv-04227 (N.D. Cal. 2008). Court appointed Special Master. Preparing Report and Recommendation on the order of patents, claims and terms to be adjudicated in litigation involving multiple patents related to OCR technology.
  • Urologix, Inc. v. Prostalund AB, 227 F. Supp. 2d 1033 (E.D. Wis. 2002), reconsideration denied, 256 F. Supp. 2d 911 (E.D. Wis. 2003). Court Appointed Assistant. Prepared patent claim construction recommendations and summary judgment recommendations to the district court in patent litigation concerning a medical device.
  • Omega Mfg. Corp. v. Valley Tissue Pkg., Inc., No. 95-CV-1323 (E.D. Wis. dismissed 2002). Appointed Special Master. Conducted hearing on patent claim construction; prepared claim construction decision and prepared recommendations adopted by the district court on discovery motions in patent litigation relating to packaging of paper products.
  • Microelectronic Modules Corp. v. Maxim Integrated Prods., Inc., No. 01-CV-272 (E.D. Wis. filed 2001). Court Appointed Expert. Prepared patent claim construction recommendations and summary judgment recommendations to the district court in patent litigation concerning electrical circuitry.
  • Allen-Bradley Co., Inc. v. DataLink Techs., Inc., No. 97-CV-927 (E.D. Wis. filed 1997). Court Appointed Assistant. Prepared patent claim construction recommendations and summary judgment recommendations to the district court in complex patent litigation involving patents relating to programmable controllers for integrating multiple computer systems.
  • HK Systems, Inc. v. Mannesmann Dematic Rapistan Corp., 86-C-381 (E.D. Wis. filed 2000). Court Appointed Expert Assistant on claim construction issues and summary judgment motions on patents for automatic guided vehicles.
District Court Cases
View All
  • Merck v. Sandoz Inc., (D. Del. filed Jan. 8, 2010). Litigating patents under Hatch Waxman related to Caspofungin sold by Merck as Cancidas ®.
  • Allergan v. Sandoz Inc., 10-cv-00024 (D. Del. filed Jan. 8, 2010). Litigating patents under Hatch Waxman related to bimatoprost sold by Allergan as Lumigan®.
  • Novo Nordisk Inc. v. Sandoz Inc., 09-cv-9217 (S.D.N.Y. filed Nov. 5, 2009). Litigating patents under Hatch Waxman related to repaglinide and metformin sold by Novo Nordisk as Prandimet®.
  • Genzyme Corp. v. Sandoz Inc., 09-cv-1750 (D. Md. filed June 6, 2009). Litigating patents under Hatch Waxman related to doxercalciferol sold by Genzyme as Hectorol®.
  • Pfizer v. Sandoz Inc., 09-cv-2052 (D.N.J. filed April 30, 2009). Litigating patents under Hatch Waxman related to pregabalin sold by Pfizer as Lyrica®.
  • Genzyme v. Sandoz Inc., 09-cv-0524 (D. Del. filed July 16, 2009). Litigating patents under Hatch Waxman related to sevelamer sold by Genzyme as Renagel®.
  • Eli Lilly and Co. v. Sandoz Inc., 08-cv-1548 (S.D.IN filed Nov. 14, 2008); Eli Lilly and Co. v. Sandoz Inc., 08-cv-6124 (D.N.J. filed Dec. 12, 2008). Representing Sandoz in Hatch Waxman litigation over Eli Lilly's patent relating to the anti-depressant Cymbalta® and accusations of infringement by Sandoz generic duloxetine.
  • Nycomed GmbH, et al v. Sandoz Inc., 08-cv-2871 (N.D.Ill. filed May 16, 2008). Represented Sandoz in Hatch Waxman litigation over Wyeth's patent relating to the proton pump inhibitor Protonix® and accusations of infringement by Sandoz generic pantoprazole.
  • Janssen Pharmaceutica N.V., et al v. Sandoz Inc., No. 07-cv-2058 (D.N.J. filed May 2, 2007); Janssen, L.P. et al v. Sandoz Inc., No. 08-cv-2892 (D.N.J. filed June 9, 2008); Janssen Pharmaceutica N. V. et al v. Sandoz Inc., No. 08-cv-511 (D.Del. filed August 13, 2008). Represented Sandoz in Hatch Waxman litigations over Janssen's patents relating to the Alzheimer's drug Razadyne® and accusations of infringement by Sandoz generic galantamine.
  • Abbott Labs. v. Sandoz Inc., 486 F. Supp. 2d 767 (N.D. Ill. 2007), aff'd, 566 F.3d 1282 (Fed. Cir.) (partially en banc), cert. denied, 09-335 (2009). Represented Sandoz against request for temporary restraining order and preliminary injunction by Abbott over patents relating to the antibiotic Omnicef® and generic Cefdinir.
  • Aventis Pharma, S.A. v. Sandoz Inc., 07-cv-3658 (C.D. Cal. filed Jun. 6, 2007); Aventis Pharma. S.A. v. Sandoz Inc., 06-cv-4858 (C.D. Cal. filed Aug. 4, 2006); Aventis Pharma. S.A. v. Sandoz Inc., 06-cv-3671 (D.N.J. filed Aug. 4, 2006). Represented Sandoz in litigations over Aventis patent relating to Lovenox® and accusation of infringement by Sandoz forms of Enoxaparin.
  • NeoMedia Tech., Inc. v. Virgin Ent., Group et al., Civ. No. 04-cv-00021 (N.D. Ill. dismissed July 13, 2005). Represented Defendant Virgin in patent litigation involving technology for scanning UPC codes on store items to preview music, movies, or art, etc.
  • Ever Win Int'l v. Motorola, No. 04-cv-1059 (C.D. Cal. 2004). Represented Defendant Motorola in declaratory judgment action relating to infringement of Motorola's patent, design patents, and copyrights on batteries for mobile devices, such as cellular phones.
  • Energy Trans., Group v. Sonic Innovations et al., No. 05-ca-422 (D. Del. 2004). Represented Defendant Phonak in multi-defendant litigation relating to electronic circuits for hearing aids.
  • Motorola, Inc. and GMP/Wireless Med., Inc. v. Nonin Med., Inc., Civ. No. 04-C-5944 (N.D. Ill. filed Sept. 10, 2004). Represented Plaintiff Motorola in patent litigation against Nonin relating to wireless diagnosis and medical equipment.
  • Multi-Tech Sys., Inc. v. VocalTec Communications Inc., Nos. 00-CV-1541, 00-CV-346 (D. Minn. filed Feb. 15, 2000). Represented Defendant VocalTec in patent litigation involving voice over Internet technology.
  • AMP Incorporated v. Teradyne Inc., No. 4:CV-98-0975 (M.D. Pa. filed June 19, 1998). Represented Plaintiff AMP Inc. in patent litigation over electrical connectors.
Pro Bono
  • Gardin v. Shinseki, No. 2009-7120 (Fed. Cir. filed 2009). Lead counsel for pro bono veteran of successful appeal of denial of veteran’sbenefits for diabetes.
  • Smith v. Nicholson, No. 06-400 (U.S.S.Ct. 2007). Counsel on pro bono petition for writ of certiorari to the Federal Circuit for the United States Supreme Court to review proper standard of Article III and Article I courts' review of veterans' benefits. Petition was denied.
  • Tyndall v. Principi, No. 00-7163 (Fed. Cir. filed 2000). Lead counsel in a pro bono appeal of denial of benefits to the widow of World War II veteran. Negotiated a settlement with the Department of Justice representing the Veterans Administration for the entire relief requested on appeal. The widow received benefits for her husband's disability and death.
  • King v. Chapman et. al., No. 09-C-1184 (N.D. Il. filed 2009). Representing prisoner on 1983 case.
Testimony
Publications
Feature Profiles
  • "Patented Path to Success: The Quick Rise of Meredith Addy," Illinois Super Lawyers, February 2009, William Wagner
  • "40 Under 40: Meredith Martin Addy," Illinois Super Lawyers, 2004
  • "Advocating for Our Members & ALl Veterans," Paralyzed Veterans of America Annual Report, 2004 (profile of Meredith Martin Addy's successful pro bono representation at the Federal Circuit)
Published Articles
View All
Presentations
View All
  • “From the Bench to the Bar: Advice for IP Litigators,” Moderator, IPLAC Sixth Annual Federal Judicial Panel, Chicago, Illinois, July 20, 2010
  • “Patentable Subject Matter After the Supreme Court Bilski Opinion,” panelist, DePaul University College of Law Bench & Bar Horizons Seminar Series, Chicago, Illinois, July 1, 2010
  • "The Bilski Effect: Recent and Potential Sea-Changes for Statutory Subject Matter," panelist, Practising Law Institute's 4th Annual Patent Law Institute, PLI California Center, San Francisco, California, March 22, 2010
  • "Patentable Subject Matter After the Supreme Court Bilski Opinion," panelist, The Federal Circuit Bar Association and DePaul University, Chicago, Illinois, March 16, 2010
  • "The Why's and How's of Amicus Briefing," with Charlie McMahon, Wisconsin Intellectual Property Law Association, March 11, 2010
  • "District Court Application of KSR," 2010 Mid-Winter Institute, American Intellectual Property Law Association, La Quinta, California, January 28, 2009
  • "In re Bilski Roundtable: Views From Participants on the Case and Business Method Patent Law," Indiana Continuing Legal Education Forum's 2009 Midwest Intellectual Property Symposium, Indianapolis, Indiana, November 20, 2009
  • "Best Practices: Investigating the Distinctions in Trial and Appellate Practice," moderator for panel that included 2 Federal Circuit Judges and 2 Illinois District Court Judges, Intellectual Property Law Association of Chicago, Patent Law Symposium 2009, Chicago, Illinois, September 25, 2009
  • "Bilski - What is the Future for Business Method Patents," 2009 IPO Annual Meeting, Chicago, Illinois, September 15, 2009
  • "Excellence in Appellate Advocacy: Goal and Outcome" and "Excellence in Appellate Advocacy: Learning From Others' Missteps," moderator, 11th Annual Bench & Bar Conference, Chicago, Illinois, June 18-20, 2009
  • “Patentable Subject Matter After Bilski,” 53rd Annual Intellectual Property Law Conference, The John Marshall Law School, Chicago, Illinois, February 27, 2009
  • “How Equitable Relief Drives Pre-Trial Decisions,” 2009 Mid-Winter Institute, American Intellectual Property Law Association, Miami, Florida, January 30, 2009
  • "Patentable Subject Matter: Anything Under the Sun Made by Man...Really?" 5th Annual Federal Circuit Roundtable Discussion, Chicago, Illinois, October 15, 2008
  • "Successful Strategies at the Federal Circuit," Intellectual Property Law Association of Chicago, Patent Law Symposium 2008, Chicago, Illinois, October 10, 2008
  • "Patent Issues Ripe for Judicial Clarification," United States Court of Appeals for the Federal Circuit, Judicial Conference, May 15, 2008
  • "Working With Expert Witnesses in IP Cases," 52nd Annual Intellectual Property Law Conference in Patent, Trademark, Copyright & Trade Secrets Law, The John Marshall Law School, February 29, 2008
  • “Claim Construction on Appeal: Dealing with Cybor,” Law Seminars International, February 15, 2008
  • "So What's in your Patent Portfolio-This Year?" Institute for Corporate Counsel, December 6, 2007
  • "The Impact of Post-KSR Court Decisions and PTO Guidelines on Obviousness Issues," Horizons Seminar Series, The Federal Circuit Bar Association, November 9, 2007
  • "Demonstration of a Direct and Cross-Examination of a Technical Expert Contending for Obviousness," Patent Litigation 2007, Practising Law Institute, The Gleacher Center, Chicago, Illinois, October, 11, 2007
  • "Obviousness in Patent Litigation: KSR International v. Teleflex," panelist, The Intellectual Property Law Association of Chicago and The John Marshall Law School, Chicago, Illinois, May 18, 2007
  • "Civil Litigation: Patent Litigation Reform in the Courts and Congress," Seventh Circuit Bar Association & Judicial Conference of the Seventh Circuit, The Pfister Hotel, Milwaukee, Wisconsin, May 8, 2007
  • “Bench/Bar Dialogue – Jury Instructions in Patent Cases,” The John Marshall Law School Annual Intellectual Property Law Conference in Patent, Trademark, Copyright and Trade Secrets Law, The John Marshall Law School, Chicago, Illinois, February 23, 2007
  • "Handling Claim Construction on Appeal," Patent Claim Construction Workshop, Law Seminars International, The Gleacher Center, Chicago, Illinois, February 17, 2007
  • "Not So Obvious: Patent Law, the Supreme Court, and KSR International," 3rd Annual Federal Circuit Roundtable Discussion, IIT Chicago-Kent College of Law, Chicago, Illinois, November 1, 2006
  • "Willfulness After Knorr-Bremse," moderator, The Judicial Conference for the United States Court of Appeals for the Federal Circuit, Grand Hyatt Hotel, Washington, DC, May 19, 2006
  • "Handling Claim Construction on Appeal," speaker, New Developments in Patent Claim Construction, Law Seminars International, The Gleacher Center, Chicago, Illinois, February 17, 2006
  • "Strategies for Addressing the Key Issues in Claim Construction Today," panelist, New Developments in Patent Claim Construction, Law Seminars International, The Gleacher Center, Chicago, Illinois, February 17, 2006
  • "The Statutory Research Infringement Exemption: How Far Back is 'Reasonably Related?'" Advanced Patent Law Institute, The Fairmont Hotel, San Jose, California, December 2, 2005
  • "The Enablement/Written Description Debate," moderator four-judge, three-attorney panel, jointly sponsored by IPLAC and FCBA, November 7, 2005
  • "Federal Circuit Clerks Roundtable: Waiving Your Patent Case Goodbye," panelist, 9th Annual Charles Green Lecture in Law and Technology, IIT Chicago-Kent College of Law, Chicago, Illinois, October 31, 2005
  • "The Federal Circuit: Preserving the Wins, and Reversing the Losses," presentation with Cynthia A. Homan at Brinks Hofer Gilson & Lione Seminar, "Managing the Risks of IP Litigation," October 25, 2005
  • "Phillips v. AWH Corp. IPLAC Panel Discussion," panelist, The John Marshall Law School, September 30, 2005
  • "Standards Bodies & Patent Pools," program co-chair, presenter: "Patent Pools: How They Work," Law Seminars International, Mid-America Club, Chicago, Illinois, July 18, 2005
  • “The 'New' Rubric for Claim Construction," 49th Annual Conference on Continuing Developments in Intellectual Property Law, The John Marshall Law School, Chicago, Illinois, 2005
  • "Willful Patent Infringement: Ramifications of Knorr-Bremse," moderator, three-judge panel, IPLAC Judges' Dinner, Chicago, Illinois, November 19, 2004
  • "Knorr-Bremse v. Dana Corporation: How This Landmark Decision May Affect Your Company," Brinks Hofer Gilson & Lione Client Seminar, Chicago, Illinois, October 12, 2004 and November 3, 2004
  • "Federal Circuit Clerks Roundtable: Recent Developments in the Federal Circuit and Patent Law," panelist, 8th Annual Charles Green Lecture in Law and Technology, IIT Chicago-Kent College of Law, Chicago, Illinois, October 25, 2004
  • "Patent Law for Business People and Non-Patent Lawyers," program co-chair, Law Seminars International, Mid-America Club, Chicago, Illinois, July 26, 2004
  • "Decisions in Precedent: Two Roads Diverged in a Wood," Federal Circuit's Sixth Bench & Bar Conference, 2004
  • "Amazon.com v. BarnesandNoble.com," moderator, mock oral argument, Federal Circuit Bar Association/Intellectual Property Law Association of Chicago, Chicago, Illinois, November 7, 2003
  • "Federal Circuit World v. Real World: Practical Lessons Learned by Former Clerks," Federal Circuit's Fifth Bench & Bar Conference, 2003
  • "Recent Developments in Patent Litigation," The John Marshall Law School Conference on Developments in Intellectual Property Law, Chicago, Illinois, 2001
  • "Strategies for Dealing with Festo," Brinks Hofer Gilson & Lione Client Seminar, Chicago, Illinois, 2001
Memberships & Affiliations
View All
  • U.S. Court of Appeals for the Federal Circuit
    Advisory Council, 2005-Present
    Judicial Conference, Steering Committee, 2006, 2008, 2010
  • Richard Linn American Inn of Court
    President, 2006-2009
    Executive Board, 2009-Present
    Linn Inn Alliance Advisory Board, 2009-Present
  • American Intellectual Property Law Association
    Amicus Committee, 2006-Present
    Chair, Amicus Committee, October 2007-2008
  • AIPLA Quarterly Journal
    Editorial Board, 2003-2006
  • Federal Circuit Bar Association
    Co-Chair, Annual Meeting Planning Committee, 2010
    Annual Meeting Planning Committee, 2008-2009
    Chair, George Hutchinson Writing Competition, 2002-2004
  • Intellectual Property Law Association of Chicago
    Board of Managers, 2005-2007
    Chair, Computer Technology Committee, 2002-2004
  • IP Jury Instructions Subcommittee of the Seventh Circuit Pattern Jury Instruction Committee, 2006-2008
  • Intellectual Property Owners Association
Civic Activities
  • Chicago Art Institute, 1995-Present
  • School of the Art Institute, Figure Drawing Classes, 1993-1995
  • Corcoran School of Art, Figure Drawing Classes, 1997-1998
  • Independent Studio Drawing, 1998-Present
Legal Experience
  • Brinks Hofer Gilson & Lione, Chicago, Illinois
    Shareholder, January 2000-Present
    Associate, September 1998-December 1999; August 1993-July 1997
Teaching Experience
  • The John Marshall Law School, Chicago, Illinois
    Adjunct Professor, Spring 2000-Present
    Intellectual Property Litigation
    Substantive Patent Law
    Patent Appellate Advocacy Courses on Oral Argument and Brief Writing
    Patent and Copyright Protection for Computer Software Inventions
  • IIT Chicago-Kent College Of Law, Chicago, Illinois
    Adjunct Professor, Fall 1998
    Co-taught Intensive Patent Trial Advocacy Course